Abstract: The invention provides pharmaceutical compositions comprising hypolipidemically active derivatives of 1,2,4-triazolidine-3,5-diones, 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones, and 1,3,5-triazine-2,4(1H,3H)-diones in a pharmaceutically acceptable carrier for treating hyperlipidemia in mammals, particularly humans.
Type:
Grant
Filed:
November 6, 1990
Date of Patent:
March 9, 1993
Assignees:
North Carolina Central Univ., University of North at Chapel Hill